Deep Medicine Acquisition Corp. Announces Listing Transfer to the Nasdaq Capital Market
February 16, 2023 16:25 ET
|
Deep Medicine Acquisition Corp.
New York, NY, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Deep Medicine Acquisition Corp. (Nasdaq: DMAQ) (the “Company”) announced today that it has received approval from the Nasdaq Stock Market (“Nasdaq”)...
Deep Medicine Acquisition Corp. Announces Appointment of a New Director
October 24, 2022 17:35 ET
|
Deep Medicine Acquisition Corp.
New York, NY, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Deep Medicine Acquisition Corp. (Nasdaq: DMAQ) (the “Company”) announced today the appointment of Mr. John Chiang as a member to its board of...
Deep Medicine Acquisition Corp. Confirms Funding to Extend Period to Consummate Initial Business Combination
October 20, 2022 16:30 ET
|
Deep Medicine Acquisition Corp.
New York, NY, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Deep Medicine Acquisition Corp. (Nasdaq: DMAQ) (the “Company”), announced today that an aggregate of $1,265,000 has been deposited into the Company’s...